| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4237975 | Journal of Vascular and Interventional Radiology | 2013 | 12 Pages |
Abstract
RF ablation combined with chemoembolization is a safe and useful therapeutic option for treating HCCs. Prognostic factors detected in this study help to stratify patients who benefit from this combination therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Masashi MD, Haruyuki MD, Atsuhiro MD, Junji MD, Takashi MD, Takaaki MD, Katsuya MD, Yoshiyuki MD, Hajime MD, Koichiro MD,